Fratta W - Search Results

1

Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.

Primavera D, Manchia M, Deriu L, Tusconi M, Collu R, Scherma M, Fadda P, Fratta W, Carpiniello B. Primavera D, et al. Among authors: fratta w. BMJ Open. 2017 May 25;7(5):e014938. doi: 10.1136/bmjopen-2016-014938. BMJ Open. 2017. PMID: 28550022 Free PMC article.

2

Cannabinoids and their therapeutic applications in mental disorders .

Scherma M, Muntoni AL, Riedel G, Fratta W, Fadda P. Scherma M, et al. Among authors: fratta w. Dialogues Clin Neurosci. 2020 Sep;22(3):271-279. doi: 10.31887/DCNS.2020.22.3/pfadda. Dialogues Clin Neurosci. 2020. PMID: 33162770 Free PMC article. Review.

3

The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence.

Scherma M, Fattore L, Castelli MP, Fratta W, Fadda P. Scherma M, et al. Among authors: fratta w. Curr Pharm Des. 2014;20(13):2089-99. doi: 10.2174/13816128113199990429. Epub 2013 Jul 9. Curr Pharm Des. 2014. PMID: 23829365 Review.

4

Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat.

Serra V, Fattore L, Scherma M, Collu R, Spano MS, Fratta W, Fadda P. Serra V, et al. Among authors: fratta w. Psychopharmacology (Berl). 2015 Jan;232(1):91-100. doi: 10.1007/s00213-014-3641-z. Epub 2014 Jun 13. Psychopharmacology (Berl). 2015. PMID: 24923984

5

Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.

Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M. Scherma M, et al. Among authors: fratta w. Psychopharmacology (Berl). 2016 May;233(10):1765-77. doi: 10.1007/s00213-015-4196-3. Epub 2016 Jan 4. Psychopharmacology (Berl). 2016. PMID: 26728894 Review.

6

Emotional profile of female rats showing binge eating behavior.

Satta V, Scherma M, Giunti E, Collu R, Fattore L, Fratta W, Fadda P. Satta V, et al. Among authors: fratta w. Physiol Behav. 2016 Sep 1;163:136-143. doi: 10.1016/j.physbeh.2016.05.013. Epub 2016 May 11. Physiol Behav. 2016. PMID: 27180132 No abstract available.

7

Cannabinoid CB₁ /CB₂ receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.

Scherma M, Satta V, Collu R, Boi MF, Usai P, Fratta W, Fadda P. Scherma M, et al. Among authors: fratta w. Br J Pharmacol. 2017 Aug;174(16):2682-2695. doi: 10.1111/bph.13892. Epub 2017 Jul 11. Br J Pharmacol. 2017. PMID: 28561272 Free PMC article.

8

Brain activity of anandamide: a rewarding bliss?

Scherma M, Masia P, Satta V, Fratta W, Fadda P, Tanda G. Scherma M, et al. Among authors: fratta w. Acta Pharmacol Sin. 2019 Mar;40(3):309-323. doi: 10.1038/s41401-018-0075-x. Epub 2018 Jul 26. Acta Pharmacol Sin. 2019. PMID: 30050084 Free PMC article. Review.

9

Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa.

Collu R, Scherma M, Piscitelli F, Giunti E, Satta V, Castelli MP, Verde R, Fratta W, Bisogno T, Fadda P. Collu R, et al. Among authors: fratta w. Int J Eat Disord. 2019 Nov;52(11):1251-1262. doi: 10.1002/eat.23157. Epub 2019 Aug 27. Int J Eat Disord. 2019. PMID: 31456239

10

Gene knockout animal models of depression, anxiety and obsessive compulsive disorders.

Scherma M, Giunti E, Fratta W, Fadda P. Scherma M, et al. Among authors: fratta w. Psychiatr Genet. 2019 Oct;29(5):191-199. doi: 10.1097/YPG.0000000000000238. Psychiatr Genet. 2019. PMID: 31464999 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page